Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Jensen

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
International Disability Studies|July 1, 1991
Driving after stroke: a controlled laboratory investigationS Lings, P B Jensen
Scandinavian Journal of Gastroenterology|January 1, 1973
Electrolyte transport capacity and electrical potentials of the normal and the inflamed human rectum in vivoJ Rask-Madsen, P B Jensen
British Journal of Cancer|August 1, 1995
Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecanM Sorensen, M Sehested, P B Jensen
Cancer Chemotherapy and Pharmacology|January 1, 1996
ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumorsB Holm, P B Jensen, M Sehested
The Journal of Biological Chemistry|June 22, 1999
Evidence for repressional role of an inverted CCAAT box in cell cycle-dependent transcription of the human DNA topoisomerase IIalpha geneJ Falck, P B Jensen, M Sehested
Biochemical Pharmacology|August 1, 1997
pH-dependent regulation of camptothecin-induced cytotoxicity and cleavable complex formation by the antimalarial agent chloroquineM Sorensen, M Sehested, P B Jensen
Molecular Pharmacology|March 3, 1999
Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation Of cleavable-complex formation by etoposide but not by amsacrineM Sorensen, M Sehested, P B Jensen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Dexrazoxane for protection against cardiotoxic effects of anthracyclinesM Sehested, B Holm, P B Jensen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposideB Holm, M Sehested, P B Jensen
Cancer Chemotherapy and Pharmacology|January 1, 1992
Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumorE Friche, P B Jensen, N I Nissen
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
International Disability Studies|July 1, 1991
Driving after stroke: a controlled laboratory investigationS Lings, P B Jensen
Scandinavian Journal of Gastroenterology|January 1, 1973
Electrolyte transport capacity and electrical potentials of the normal and the inflamed human rectum in vivoJ Rask-Madsen, P B Jensen
British Journal of Cancer|August 1, 1995
Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecanM Sorensen, M Sehested, P B Jensen
Cancer Chemotherapy and Pharmacology|January 1, 1996
ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumorsB Holm, P B Jensen, M Sehested
The Journal of Biological Chemistry|June 22, 1999
Evidence for repressional role of an inverted CCAAT box in cell cycle-dependent transcription of the human DNA topoisomerase IIalpha geneJ Falck, P B Jensen, M Sehested
Biochemical Pharmacology|August 1, 1997
pH-dependent regulation of camptothecin-induced cytotoxicity and cleavable complex formation by the antimalarial agent chloroquineM Sorensen, M Sehested, P B Jensen
Molecular Pharmacology|March 3, 1999
Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation Of cleavable-complex formation by etoposide but not by amsacrineM Sorensen, M Sehested, P B Jensen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Dexrazoxane for protection against cardiotoxic effects of anthracyclinesM Sehested, B Holm, P B Jensen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposideB Holm, M Sehested, P B Jensen
Cancer Chemotherapy and Pharmacology|January 1, 1992
Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumorE Friche, P B Jensen, N I Nissen
Pageof 12